EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+5.25%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$1.88B
AUM Growth
+$96.1M
(+5.4%)
Cap. Flow
+$12.6M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
23.84%
Holding
1,015
New
26
Increased
115
Reduced
94
Closed
18
Top Buys
| 1 |
Foot Locker
FL
|
$25.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
$24M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$8.73M |
| 4 |
Goosehead Insurance
GSHD
|
$8.5M |
| 5 |
Alibaba
BABA
|
$7.74M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$66.9M |
| 2 |
Openlane
KAR
|
$9.83M |
| 3 |
Biogen
BIIB
|
$9.52M |
| 4 |
Microsoft
MSFT
|
$8.81M |
| 5 |
Constellation Brands
STZ
|
$7.76M |
Sector Composition
| 1 | Healthcare | 31.61% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Financials | 9.85% |
| 5 | Communication Services | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Morgan Stanley
MS
$240B
| $2.53M | 0.13% |
57,729
-35,500
| -38% | -$1.56M |
|
152
Brookfield Renewable
BEP
$7.09B
| $2.49M | 0.13% |
135,108
+65,678
| +95% | +$1.21M |
|
153
Wabtec
WAB
$33.1B
| $2.47M | 0.13% |
35,783
+4,998
| +16% | +$345K |
|
154
Chevron
CVX
$318B
| $2.4M | 0.13% |
19,450
| – | – |
|
155
BCE
BCE
$22.8B
| $2.3M | 0.12% |
50,300
+6,200
| +14% | +$283K |
|
156
McDonald's
MCD
$226B
| $2.29M | 0.12% |
+11,100
| New | +$2.29M |
|
157
Prudential Financial
PRU
$38.3B
| $2.23M | 0.12% |
22,500
| – | – |
|
158
Essential Utilities
WTRG
$10.9B
| $2.22M | 0.12% |
55,000
+19,000
| +53% | +$768K |
|
159
Marsh & McLennan
MMC
$101B
| $2.19M | 0.12% |
22,000
| – | – |
|
|
ZNGA
160
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $2.17M | 0.12% |
360,000
| – | – |
|
161
Bank of America
BAC
$375B
| $2.17M | 0.12% |
76,910
+9,920
| +15% | +$280K |
|
|
FPRX
162
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.14M | 0.11% |
354,750
+79,000
| +29% | +$477K |
|
163
Elevance Health
ELV
$69.4B
| $2.08M | 0.11% |
7,370
| – | – |
|
|
RETA
164
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.07M | 0.11% |
+22,600
| New | +$2.07M |
|
165
Canadian Imperial Bank of Commerce
CM
$73.6B
| $2.06M | 0.11% |
52,800
+16,200
| +44% | +$632K |
|
|
PRAH
166
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.03M | 0.11% |
21,200
| – | – |
|
167
Rogers Communications
RCI
$19.2B
| $2.02M | 0.11% |
38,000
-75,300
| -66% | -$4M |
|
168
DuPont de Nemours
DD
$32.3B
| $1.99M | 0.11% |
26,982
+1,728
| +7% | +$128K |
|
|
SYNH
169
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.99M | 0.11% |
40,000
| – | – |
|
|
170
Constellation Brands
STZ
$25.7B
| $1.97M | 0.1% |
10,480
-41,220
| -80% | -$7.76M |
|
171
Ross Stores
ROST
$50B
| $1.97M | 0.1% |
19,635
-4,600
| -19% | -$462K |
|
172
American Water Works
AWK
$27.6B
| $1.96M | 0.1% |
17,000
-3,000
| -15% | -$346K |
|
173
Bank of Montreal
BMO
$89.7B
| $1.95M | 0.1% |
25,900
+8,200
| +46% | +$618K |
|
174
ICICI Bank
IBN
$114B
| $1.95M | 0.1% |
154,750
+30,000
| +24% | +$378K |
|
175
Amicus Therapeutics
FOLD
$2.47B
| $1.9M | 0.1% |
158,600
| – | – |
|